ESTRO35 Programme Book

> CyberKnife for prostate cancer patients – early results of 350 patients irradiation L. Miszczyk, A. Namysl-Kaletka (Poland), A. Napieralska, G. Wozniak, M. Stapor-Fudzinska, G. Glowacki, K. Grabinska > Stereotactic body radiotherapy for localized prostate cancer: a 7-year experience Y.W. Lin (Taiwan), K.L. Lin, L.C. Lin > Early salvage RT for PSA recurrence postprostatectomy improves biochemical progression free survival A.B. Hopper (USA), A.P.S. Sandhu, J.P. Einck

PV-0089

SATURDAY 30 APRIL 2016

PV-0090

PV-0091

PRESIDENTIAL SYMPOSIUM 12:00 - 12:35 | AUDITORIUM

12:05 > Patient centric approach: myth or fact? Speaker: P. Poortmans (The Netherlands)

SP-0092

AWARD LECTURE: EMMANUEL VAN DER SCHUEREN AWARD 12:35 - 13:15 | AUDITORIUM

12:35 > Introduction

Chair: V. Valentini (Italy)

12:40 > Did I do it right? What was the result? Process and outcomes in radiotherapy Speaker: A. Barrett (UK)

SP-0093

Symposium with proffered papers HOT TOPICS IN SABR: TIME FOR RANDOMISED CLINICAL TRIALS? 14:30 - 15:45 | ROOM 2 The session will be dedicated to the role of randomised clinical trials in SABR. After reviewing the existing evidenced and lessons learned by David Palma, some biological endpoints will be presented by Martin Brown. Because the results obtained with stereotactic radiosurgery (SRS) and stereotactic ablative radiotherapy (SABR) have been impressive they have raised the question of whether classic radiobiological modeling is appropriate for large doses per fraction. Finally, Marianne Aznar will talk about developments in image guidance, treatment delivery methods (i.e. VMAT, etc...), dose calcula- tion algorithms and their common impact on the development of future clinical trials as well as the issue of common standards in normalisation and reporting of the prescription dose.

Chair: E. Lartigau (France) Co-chair: R. Ruggieri (Italy)

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

72